Dosing of BRAF and MEK inhibitors in melanoma: no point in taking a break

Jenny H. Lee, Matteo S. Carlino, Helen Rizos*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dosing of BRAF and MEK inhibitors in melanoma: no point in taking a break'. Together they form a unique fingerprint.

Medicine & Life Sciences